2023-10-04 10:08:23
ABBOTT (L-CP07-167) – Latin Clinical Trial Center

ABBOTT (L-CP07-167)

By June 19, 2019 Closed

A Phase 3, Randomized, Multi-Center, Open-Label Study To Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30mg Formulation in Children with Central Precocious Puberty.

Join the discussion 65 Comments

Leave a Reply